Per this agreement, patients from the hospitals’ seven clinics in Porto Alegre, Brazil, will be able to access medical treatment options through Clinerion’s Patient Network Explorer Platform.
This partnership will add 1.2m patients to the network as well as seven clinics and 1,023 beds.
A spokesperson for Clinerion told us that through this partnership, “patients at Santa Casa will have access to international clinical trials bringing world-class quality of care and the most innovative treatments.”
Additionally, the spokesperson explained that as patients have access to these clinical trials, “Santa Casa’s electronic health records (EHRs) may be queried by sponsors and contract research organizations (CROs) seeking sites and patients via Clinerion’s patient network explorer.”
On the clinical research side, users of the Patient Network Explorer will be able to examine the patient population in Brazil and make strategic drug development decisions from real-time, real-world data. This is the second hospital in Brazil, the other São Vicente, to be added to the Clinerion network.
By adding Santa Casa to the network, CROs and sponsors will have access to a “wider pool of patients for clinical trial recruitment and real-world evidence (RWE) data.”
It may also reduce the recruitment time for trials in the region and increases the potential number of patients recruited into trials. The spokesperson also added that having access to patient data from this hospital will increase the genetic diversity of clinical research candidates.
Clinerion has added hospitals to its network over the years to provide care to patients and data to CROs. It has established partnerships in Georgia, Estonia and Turkey, the Asia region, and the Middle East and Africa
